Kolexia
Alexandre Jerome Oncologie médicale
Alexandre Jerome
Oncologie médicale
Cabinet libéral
Paris, France
321 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Carcinomes Tumeurs du poumon Tumeurs de l'endomètre Carcinome pulmonaire à petites cellules Carcinome épithélial de l'ovaire Tumeurs de la prostate Carcinome pulmonaire non à petites cellules Récidive tumorale locale

Collaborateurs

Voir plus
Goldwasser Francois
Goldwasser Francois
Hôpital Cochin, Paris, France
Boudou-Rouquette Pascaline
Boudou-Rouquette Pascaline
Hôpital Cochin, Paris, France
Huillard Olivier
Huillard Olivier
Hôpital Cochin, Paris, France
Blanchet Benoit
Blanchet Benoit
Hôpital Cochin, Paris, France

Industries

Voir plus
MSD
28 collaboration(s)
Dernière en 2023
AstraZeneca
21 collaboration(s)
Dernière en 2023
GSK
19 collaboration(s)
Dernière en 2023
Eisai
9 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
DOMENICA: Randomized Phase III Trial in MMR Deficient Endometrial Cancer Patients Comparing Chemotherapy Alone Versus Dostarlimab in First Line Advanced/Metastatic Setting
Essai Clinique (GSK)   28 février 2024
MEDIOLA: A Phase I/II Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination With Olaparib (PARP Inhibitor) in Patients With Advanced Solid Tumors
Essai Clinique (AstraZeneca)   23 janvier 2024
TEDOVA: Randomized Phase II Study Comparing Neo-epitope Based Vaccine OSE2101 (TEDOPI®) With or Without Anti-PD1 (Pembrolizumab) Versus Best Supportive Care as Maintenance Treatment in Platinum-sensitive Recurrent Ovarian Cancer Patient With Controlled Disease After Platinum-based Chemotherapy
Essai Clinique (Merck & Co.)   04 décembre 2023
GYNET: A Randomized, Multicenter, Open Label, Phase I/II Study to Evaluate the Safety, Clinical and Biological Activity of a Humanized Monoclonal Antibody Targeting Netrin-1 (NP137) in Combination With Carboplatin Plus Paclitaxel and/or Pembrolizumab in Patients With Locally Advanced/Metastatic Endometrial Carcinoma or Cervix Carcinoma Progressing/Relapsing After at Least One Prior Systemic Chemotherapy.
Essai Clinique (NETRIS Pharma)   24 novembre 2023
LBA42 Olaparib vs placebo as maintenance therapy after platinum-based chemotherapy in advanced/metastatic endometrial cancer patients: The GINECO randomized phase IIb UTOLA trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
815P Clinical outcome of metastatic endometrial carcinoma patients treated with chemotherapy: ENDOVIE, a GINECO national observational cohort study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
793P Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
PloS one   14 septembre 2023
TAPAZ: A Randomized Phase II Study of Pazopanib and Weekly Paclitaxel in Patients With Platinum Resistant/Refractory Ovarian Cancer Who Relapse During Bevacizumab Maintenance
Essai Clinique (Novartis)   05 septembre 2023
CHIVA: Randomized Double Blind Placebo-controlled Phase II Trial of Vargatef® (Nintedanib) in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Adenocarcinoma of the Ovary, the Fallopian Tube or Serous Adenocarcinoma of the Peritoneum
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023